| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.707 | 0.003 | 0.943 | Phosphodiesterase 5A inhibitor | 0.943 0.002 DBMET00421 | DBMET00421 | |
| 0.692 | 0.002 | 0.942 | Phosphodiesterase V inhibitor | 0.942 0.002 DBMET00421 | DBMET00421 | |
| 0.546 | 0.005 | 0.797 | Phosphodiesterase inhibitor | 0.797 0.004 DBMET00421 | DBMET00421 | |
| 0.39 | 0.025 | 0.421 | Vasodilator | 0.421 0.02 DBMET00421 | DBMET00421 | |
| 0.32 | 0.004 | 0.678 | Phosphodiesterase I inhibitor | 0.678 0.002 DBMET00421 | DBMET00421 | |
| 0.35 | 0.039 | 0.35 | Cardiotonic | 0.321 0.048 DBMET00421 | ||
| 0.313 | 0.003 | 0.82 | Phosphodiesterase VI inhibitor | 0.82 0.001 DBMET00421 | DBMET00421 | |
| 0.258 | 0.003 | 0.722 | Phosphodiesterase 6D inhibitor | 0.722 0.001 DBMET00421 | DBMET00421 | |
| 0.242 | 0.014 | 0.242 | Bronchodilator | 0.204 0.018 DBMET00421 | ||
| 0.272 | 0.063 | 0.272 | Platelet antagonist | |||
| 0.194 | 0.004 | 0.565 | Phosphodiesterase 1A inhibitor | 0.565 0.001 DBMET00421 | DBMET00421 | |
| 0.164 | 0.006 | 0.645 | Phosphodiesterase 1B inhibitor | 0.645 0.002 DBMET00421 | DBMET00421 | |
| 0.168 | 0.037 | 0.168 | Nav1.3 sodium channel blocker | |||
| 0.129 | 0.002 | 0.291 | Phosphodiesterase 6C inhibitor | 0.291 0.002 DBMET00421 | DBMET00421 | |
| 0.131 | 0.016 | 0.162 | Phosphodiesterase 11A inhibitor | 0.162 0.008 DBMET00421 | DBMET00421 | |
| 0.131 | 0.016 | 0.162 | Phosphodiesterase XI inhibitor | 0.162 0.008 DBMET00421 | DBMET00421 | |
| 0.131 | 0.019 | 0.285 | Phosphodiesterase 3A inhibitor | 0.285 0.005 DBMET00421 | DBMET00421 | |
| 0.092 | 0.003 | 0.134 | Phosphodiesterase 6B inhibitor | 0.134 0.002 DBMET00421 | DBMET00421 | |
| 0.092 | 0.013 | 0.228 | Phosphodiesterase II inhibitor | 0.228 0.004 DBMET00421 | DBMET00421 | |
| 0.099 | 0.027 | 0.099 | Polo-like kinase-2 inhibitor | 0.07 0.053 DBMET00421 | ||
| 0.087 | 0.015 | 0.641 | Phosphodiesterase 1C inhibitor | 0.641 0.001 DBMET00421 | DBMET00421 | |
| 0.078 | 0.015 | 0.138 | Phosphodiesterase 3B inhibitor | 0.138 0.006 DBMET00421 | DBMET00421 | |
| 0.075 | 0.016 | 0.195 | Phosphodiesterase 2A inhibitor | 0.195 0.004 DBMET00421 | DBMET00421 | |
| 0.086 | 0.031 | 0.172 | Phosphodiesterase III inhibitor | 0.172 0.008 DBMET00421 | DBMET00421 | |
| 0.053 | 0.004 | 0.109 | Phosphodiesterase 6A inhibitor | 0.109 0.003 DBMET00421 | DBMET00421 | |
| 0.081 | 0.034 | 0.122 | Sirtuin 1 inhibitor | 0.122 0.014 DBMET00421 | DBMET00421 | |
| 0.047 | 0.003 | 0.067 | Phosphodiesterase 6G inhibitor | 0.067 0.002 DBMET00421 | DBMET00421 | |
| 0.047 | 0.003 | 0.067 | Phosphodiesterase 6H inhibitor | 0.067 0.002 DBMET00421 | DBMET00421 | |
| 0.167 | 0.126 | 0.517 | Cyclic AMP phosphodiesterase inhibitor | 0.517 0.006 DBMET00421 | DBMET00421 | |
| 0.067 | 0.045 | 0.067 | Bcl2 antagonist | |||
| 0.093 | 0.072 | 0.107 | Check point kinase 2 inhibitor | 0.107 0.059 DBMET00421 | DBMET00421 | |
| 0.126 | 0.105 | 0.126 | Anticoagulant | |||
| 0.03 | 0.014 | 0.03 | Myristoyl transferase inhibitor | |||
| 0.058 | 0.046 | 0.058 | Bcl-xL inhibitor | |||
| 0.128 | 0.121 | 0.135 | MAP kinase kinase 4 inhibitor | 0.135 0.099 DBMET00421 | DBMET00421 | |
| 0.123 | 0.12 | 0.123 | Polo-like kinase-3 inhibitor | |||
| 0.051 | 0.059 | 0.119 | Phosphodiesterase VII inhibitor | 0.119 0.006 DBMET00421 | DBMET00421 | |
| 0.017 | 0.031 | 0.038 | Histone deacetylase class IIb inhibitor | 0.038 0.013 DBMET00421 | DBMET00421 | |
| 0.017 | 0.031 | 0.038 | Histone deacetylase 6 inhibitor | 0.038 0.013 DBMET00421 | DBMET00421 | |
| 0.043 | 0.06 | 0.053 | Carbonic anhydrase II stimulant | 0.053 0.034 DBMET00421 | DBMET00421 | |
| 0.023 | 0.044 | 0.04 | Histone deacetylase 2 inhibitor | 0.04 0.018 DBMET00421 | DBMET00421 | |
| 0.017 | 0.041 | 0.034 | Histone deacetylase class II inhibitor | 0.034 0.015 DBMET00421 | DBMET00421 | |
| 0.04 | 0.071 | 0.075 | Phosphodiesterase 7A inhibitor | 0.075 0.009 DBMET00421 | DBMET00421 | |
| 0.032 | 0.071 | 0.049 | Guanylate cyclase stimulant | 0.049 0.022 DBMET00421 | DBMET00421 | |
| 0.012 | 0.05 | 0.019 | Guanylate cyclase 1 stimulant | 0.019 0.014 DBMET00421 | DBMET00421 | |
| 0.046 | 0.094 | 0.061 | ZAP-70 protein tyrosine kinase inhibitor | 0.061 0.06 DBMET00421 | DBMET00421 | |
| 0.01 | 0.059 | 0.024 | Histone deacetylase 1 inhibitor | 0.024 0.017 DBMET00421 | DBMET00421 | |
| 0.015 | 0.069 | 0.032 | Phosphodiesterase 9A inhibitor | 0.032 0.008 DBMET00421 | DBMET00421 | |
| 0.028 | 0.088 | 0.098 | Adenosine A1 receptor antagonist | 0.098 0.024 DBMET00421 | DBMET00421 | |
| 0.064 | 0.132 | 0.181 | Phosphodiesterase 7B inhibitor | 0.181 0.013 DBMET00421 | DBMET00421 | |
| 0.012 | 0.09 | 0.031 | Phosphodiesterase IX inhibitor | 0.031 0.008 DBMET00421 | DBMET00421 | |
| 0.16 | 0.249 | 0.269 | Sodium/bile acid cotransporter inhibitor | 0.269 0.109 DBMET00421 | DBMET00421 | |
| 0.051 | 0.144 | 0.104 | CDK2/cyclin A inhibitor | 0.104 0.055 DBMET00421 | DBMET00421 | |
| 0.018 | 0.138 | 0.072 | Phosphodiesterase 4A inhibitor | 0.072 0.024 DBMET00421 | DBMET00421 | |
| 0.021 | 0.155 | 0.056 | Phosphodiesterase 4C inhibitor | 0.056 0.039 DBMET00421 | DBMET00421 | |
| 0.094 | 0.231 | 0.16 | Antipruritic | 0.16 0.084 DBMET00421 | DBMET00421 | |
| 0.125 | 0.282 | 0.2 | Peptidyltransferase inhibitor | 0.2 0.099 DBMET00421 | DBMET00421 | |
| 0.039 | 0.207 | 0.126 | Cyclin-dependent kinase 2 inhibitor | 0.126 0.049 DBMET00421 | DBMET00421 | |
| 0.077 | 0.247 | 0.214 | Insulin sensitizer | 0.214 0.06 DBMET00421 | DBMET00421 | |
| 0.034 | 0.225 | 0.076 | I kappa B kinase 1 inhibitor | 0.076 0.041 DBMET00421 | DBMET00421 | |
| 0.018 | 0.227 | 0.063 | Cyclin B1 inhibitor | 0.063 0.04 DBMET00421 | DBMET00421 | |
| 0.119 | 0.338 | 0.221 | Toll-Like receptor 7 agonist | 0.221 0.176 DBMET00421 | DBMET00421 | |
| 0.023 | 0.245 | 0.054 | Cyclin H inhibitor | 0.054 0.048 DBMET00421 | DBMET00421 | |
| 0.115 | 0.346 | 0.218 | Toll-Like receptor agonist | 0.218 0.181 DBMET00421 | DBMET00421 | |
| 0.011 | 0.275 | 0.051 | Cyclin B2 inhibitor | 0.051 0.046 DBMET00421 | DBMET00421 | |
| 0.09 | 0.381 | 0.255 | Cyclin-dependent kinase 3 inhibitor | 0.255 0.015 DBMET00421 | DBMET00421 | |
| 0.012 | 0.306 | 0.065 | Phosphodiesterase 4D inhibitor | 0.065 0.06 DBMET00421 | DBMET00421 | |
| 0.016 | 0.32 | 0.106 | Cyclin-dependent kinase 1 inhibitor | 0.106 0.062 DBMET00421 | DBMET00421 | |
| 0.003 | 0.352 | 0.049 | Carbonic anhydrase IX inhibitor | 0.049 0.043 DBMET00421 | DBMET00421 | |
| 0.004 | 0.36 | 0.045 | Carbonic anhydrase XII inhibitor | 0.045 0.042 DBMET00421 | DBMET00421 | |
| 0.013 | 0.381 | 0.065 | CDK2/cyclin E2 inhibitor | 0.065 0.054 DBMET00421 | DBMET00421 | |
| 0.037 | 0.407 | 0.093 | Carbonic anhydrase XV inhibitor | 0.093 0.078 DBMET00421 | DBMET00421 | |
| 0.009 | 0.394 | 0.109 | Phosphodiesterase 4B inhibitor | 0.109 0.021 DBMET00421 | DBMET00421 | |
| 0.016 | 0.446 | 0.082 | I kappa B kinase inhibitor | 0.082 0.058 DBMET00421 | DBMET00421 | |
| 0.02 | 0.452 | 0.189 | Cyclooxygenase 2 inhibitor | 0.189 0.034 DBMET00421 | DBMET00421 | |
| 0.027 | 0.463 | 0.161 | EphB2 antagonist | 0.161 0.119 DBMET00421 | DBMET00421 | |
| 0.011 | 0.448 | 0.039 | Nicotinic acid receptor 1 agonist | 0.039 0.03 DBMET00421 | DBMET00421 | |
| 0.021 | 0.509 | 0.203 | Cyclooxygenase inhibitor | 0.203 0.041 DBMET00421 | DBMET00421 | |
| 0.019 | 0.579 | 0.121 | Electrolyte absorption antagonist | 0.121 0.035 DBMET00421 | DBMET00421 | |
| 0.004 | 0.591 | 0.134 | Phosphodiesterase IV inhibitor | 0.134 0.028 DBMET00421 | DBMET00421 | |
| 0.01 | 0.605 | 0.122 | Cyclooxygenase 1 inhibitor | 0.122 0.078 DBMET00421 | DBMET00421 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |